Akèy › Sistèm Imunitè ak Twoub › New York
Etid klinik pou Sistèm Imunitè ak Twoub nan New York
14 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Hematology Oncology Associates of Central New York-Auburn, Auburn
- Roswell Park Cancer Institute, Buffalo
- Hematology Oncology Associates of CNY at Camillus, Camillus
- ak 5 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT04242095A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT04474847Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Jun 2, 2026 · NCT05787574A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Columbia University, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078Biologics And Clinical Immunology Cohort at Sinai
- Mount Sinai, New York
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT04784364BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
- Sun River Health, Beacon
- Bedford Stuyvesant Family Health Center, Brooklyn
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT05341726Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.